title: Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells.
abstract: T cells are prominent components of both early and late atherosclerotic lesions and the role of Th1/Th2 cells subsets in the evolution and rupture of the plaque is currently under investigation. Statins, which are inhibitors of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase, exert actions beyond that of simply lowering cholesterol levels, and some effects on immune function have been reported. We studied in vitro the effects of fluvastatin on Th1/Th2 cytokine release in relation to caspase-1 activation, in human peripheral-blood mononuclear cells (PBMC) stimulated or not with Mycobacterium tuberculosis. Fluvastatin treatment resulted in the activation of caspase-1 and in a small secretion of interleukin (IL)-1beta, IL-18, and IFNgamma (Th1). In the presence of bacteria, the release of these cytokines was highly increased by the statin in a synergistic way. By contrast, production of IL-12, IL-10 and IL-4 were unaffected by the statin. Not only did mevalonate abolish the effects of the statin but it also prevented the caspase-1 activation induced by the bacteria, suggesting the involvement of isoprenoids in the response to M. tuberculosis. It is proposed that inhibition of HMG-CoA reductase may be immunoprotective by enhancing the Th1 response, which has therapeutical potential not only in atherosclerosis but also in infectious diseases.
authors.affiliation: Servicio de Bioquímica-Investigación, Hospital Ramón y Cajal, Madrid, Spain.
authors.forename: M T
authors.initials: MT
authors.lastname: Montero
authors.forename: O
authors.initials: O
authors.lastname: Hernández
authors.forename: Y
authors.initials: Y
authors.lastname: Suárez
authors.forename: J
authors.initials: J
authors.lastname: Matilla
authors.forename: A J
authors.initials: AJ
authors.lastname: Ferruelo
authors.forename: J
authors.initials: J
authors.lastname: Martínez-Botas
authors.forename: D
authors.initials: D
authors.lastname: Gómez-Coronado
authors.forename: M A
authors.initials: MA
authors.lastname: Lasunción
mesh_terms: D020170:Caspase 1 / Q000378:metabolism*; D016207:Cytokines / Q000378:metabolism*; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology; D000077340:Fluvastatin; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D007211:Indoles / Q000494:pharmacology; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D018417:Th1 Cells / Q000378:metabolism
chemical_list: D016207:Cytokines; D005229:Fatty Acids, Monounsaturated; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D000077340:Fluvastatin; D006903:Hydroxymethylglutaryl CoA Reductases; D020170:Caspase 1